|Class Period:||May-10-07 to Oct-31-08|
|Lead Plaintiff Deadline:||Feb-10-09|
|Court:||Southern District of Ohio|
The complaint charges AtriCure and certain of its officers with violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by failing to disclose that AtriCure misrepresented its profitability by, among other things, illegally promoting its products contrary to FDA regulations and filing false claims for Medicare reimbursement. The complaint alleges that defendants issued a series of materially false and misleading statements and SEC filings concerning the Company's operations, finances and performance and that the price of AtriCure common stock to investors was artificially inflated during the Class Period.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.